Prevention of bioprosthetic heart valve tissue calcification by charge modification: Effects of protamine binding by formaldehyde3
Authors:
- 1 January 1991
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research
- Vol. 25 (1) , 85-98
Abstract
Calcification is the principal cause of the clinical failure of bioprosthetic heart valves (BHV). Calcification occurs through an interaction of host and implant factors, mainly younger age and glutaraldehyde pretreatment, respectively. The hypothesis of this work was that an impaired balance between positively and negatively charged amino acids, due to the reaction with Lys and Hyl tissue‐collagen residues, expose affinity sites to Ca++. We further hypothesized that regardless of the cause(s) of BHV calcification, positive charge modification of the tissues will prevent their propensity to calcify. Modification of BHV tissue was obtained by covalently binding protamine sulfate, a polybasic peptide, via formaldehyde and subsequent glutaraldehyde tissue crosslinking. Protamine‐bound tissue exhibited stability properties (shrinkage temperature and resistance to collagenase digestion) similar to BHV tissue. Protamine‐treated tissue was less permeable to Ca++, and reduced staining was observed with positively charged dyes, indicating the presence of positively charged functional groups in the modified tissue. Significant prevention of calcification was exhibited by the p‐bound tissue in comparison to BHV tissue, 30.9 and 109 μg/mg calcium, respectively, after 30 days of subdermal implants in rats. The modification procedure resulted in stable, covalent links of approximately 10% w/w protamine with undiminished anticalcification properties, even after 1 year storage. The results support our hypotheses, and orthotopical heart valve replacements are required in order to completely evaluate the treatment efficacy and bio‐compatibility.Keywords
This publication has 16 references indexed in Scilit:
- Chemically modified collagen: A natural biomaterial for tissue replacementJournal of Biomedical Materials Research, 1987
- Controlled-Release Drug Delivery of Diphosphonates to Inhibit Bioprosthetic Heart Valve Calcification: Release Rate Modulation with Silicone Matrices Via Drug Solubility and Membrane CoatingJournal of Pharmaceutical Sciences, 1987
- Controlled release of diphosphonate to inhibit bioprosthetic heart valve calcification: Dose-response and mechanistic studiesJournal of Controlled Release, 1986
- Porcine Bioprosthetic Valve Calcification in Bovine Left Ventricle-Aorta Shunts: Studies of the Deposition of Vitamin K-Dependent ProteinsThe Annals of Thoracic Surgery, 1983
- Bioprosthetic valvular failureThe Journal of Thoracic and Cardiovascular Surgery, 1982
- Calcific deposits in porcine bioprostheses: Structure and pathogenesisThe American Journal of Cardiology, 1980
- Chemical Cross-Linking: Reagents and Problems in Studies of Membrane StructureAnnual Review of Biochemistry, 1977
- A rapid, sensitive, and versatile assay for protein using Coomassie brilliant blue G250Analytical Biochemistry, 1977
- Theoretical and practical aspects of glutaraldehyde fixationJournal of Molecular Histology, 1972
- Reaction of Formaldehyde with Proteins. II. Participation of the Guanidyl Groups and Evidence of CrosslinkingJournal of the American Chemical Society, 1946